SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artŪculo

MARCO, A.; SAIZ DE LA HOYA, P.; GARCIA-GUERRERO, J. ¬†y¬† GRUPO PREVALHEP. Estudio multic√©ntrico de Prevalencia de Infecci√≥n por el VIH y factores asociados en las prisiones de Espa√Īa. Rev. esp. sanid. penit. [online]. 2012, vol.14, n.1, pp.19-27. ISSN 1575-0620.

    1. WHO. Global report: UNAIDS report on the global AIDS epidemic 2010 (Internet). Geneva: WHO; 2010. (cited 2011 Apr 10). Available from: http://www.unaids.org/documents/20101123_GlobalReport_em.pdf [ Links ]

    2. Vigilancia Epidemiológica del SIDA en España. Registro Nacional de Casos de SIDA. Actualización a 30 de junio de 2010. [Internet]. Madrid: Ministerio de Sanidad, Política Social e Igualdad; 2010. [ citado 11 abr 2011]. Disponible en: http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fdenfermedades/SPNS_Informe_semestral.pdf [ Links ]

    3. Vigilancia epidemiológica del VIH en España: nuevos diagnósticos de VIH en España, periodo 2003-2009. Sistemas de Información sobre nuevos diagnósticos de VIH autonómicos. Actualización 30 de junio de 2010. [Internet]. Madrid: Ministerio de Sanidad, Política Social e Igualdad; 2010. [ citado 12 abr 2011]. Disponible en http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/fd-sida/nuevos_diagnosticos_ccaa.pdf [ Links ]

    4. Van de Laar MJ, Likatavicius G. HIV and AIDS in the European Union, 2008. Euro Surveill 2009; 14. pii: 19422. [ Links ]

    5. Infección por VIH y SIDA en España. Plan Multisectorial 2001-2005. Actualización noviembre de 2003. [Internet]. Madrid: Ministerio de Sanidad, y Consumo; 2003. [ citado 13 abr 2011]. Disponible en: http://www.msps.es/ciudadanos/enfLesiones/enfTransmisibles/sida/docs/Indicadores_nov2003.pdf [ Links ]

    6. Castilla J, Sobrino P, Lorenzo JM, Moreno C, Izquierdo A, Lezaun ME, et al. Situación presente y futuras perspectivas de la epidemia del HIV y SIDA en España. An Sist Sanit Navar. 2006; 29: 13-25. [ Links ]

    7. Hernández-Fernández T, Arroyo-Cobo JM. Resultados de la experiencia española: una aproximación global al VIH y al VHC en prisiones. Rev Esp Sanid Penit. 2010; 12: 86-90 [ Links ]

    8. Faílde JM, Lameiras M. Evolución de los conocimientos y prácticas de riesgo en relación a la infección por VIH/SIDA en la Prisión Provincial de Pereiro de Aguiar (Ourense). Estudio comparativo 1996-2003. Rev Esp Sanid Penit. 2005; 7: 42-51. [ Links ]

    9. Moreno R, Vera-Remartínez E, García-Guerrero J, Planelles Ramos MV. Consumo de drogas al ingreso en prisión: comparación entre población española y extranjera. Rev Esp Sanid Penit. 2008; 10: 41-8. [ Links ]

    10. Marco A, Sarriera C, Saiz de la Hoya P. Abordaje del paciente infectado por el virus de la hepatitis C en prisión. Avances en Hepatitis. 2009; 1: 15-22. [ Links ]

    11. Martín-Sánchez M. Programa de prevención y control de enfermedades transmisibles en instituciones penitenciarias. Revista de Estudios Penitenciarios. Monográfico de Sanidad Penitenciaria. Madrid extra 1-1990: 51-67. [ Links ]

    12. Martín V, Bayas JM, Laliga A, Pumarola T, Vidal J, Jiménez de Anta MT, et al. Seroepidemiology of HIV-1 infection in a Catalonian penitentiary. AIDS. 1990; 4: 1023-6. [ Links ]

    13. Saiz de la Hoya P, Bedia M, Murcia J, Cebriá J, Sánchez-Payá J, Portilla J. Factores predictivos de infección por el VIH, VHC y coinfección en la población reclusa de una prisión española. Enferm Infecc Microbiol Clin. 2005; 23: 53-7. [ Links ]

    14. Martín-Sánchez V, López-Caleya JF, Núñez MG, Morís ML, Pérez-Vicente R, Caylà JA. HCV and HIV infection, and coinfection in the León health area in the period 1993-2004. Rev Esp Salud Publica. 2009; 83: 533-41. [ Links ]

    15. Babudieri S, Starnini G, Brunetti B, Carbonara S, D'Offizi GP, Monarca R, et al. HIV and related infections in Italian penal institutions: epidemiological and health organization note. Ann Ist Super Sanita. 2003; 39: 251-7. [ Links ]

    16. HIV and prisons. Number of HIV-positive inmates decreases for 5th straight year. AIDS Policy Law. 2006; 21: 1. [ Links ]

    17. Calzavara L, Ramuscak N, Burchell AN, Swantee C, Myers T, Ford P, et al. Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities. CMAJ. 2007; 177: 257-61. [ Links ]

    18. Poulin C, Alary M, Lambert G, Godin G, Landry S, Gagnon H, et al. Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons. CMAJ. 2007; 177: 252-6. [ Links ]

    19. Butler T, Boonwaat L, Hailstone S, Falconer T, Lems P, Ginley T, et al. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey. Aust N Z J Public Health. 2007; 31: 44-50. [ Links ]

    20. Behrendt C, Kendig N, Dambita C, Horman J, Lawlor J, Vlahov D. Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol. 1994; 139: 918-26. [ Links ]

    21. Rosen DL, Schoenbach VJ, Wohl DA, White BL, Stewart PW, Golin CE.. Characteristics and behaviors associated with HIV infection among inmates in the North Carolina prison system. Am J Public Health. 2009; 99: 1123-30. [ Links ]

    22. Rotily M, Weilandt C, Bird SM, Käll K, Van Haastrecht HJ, Iandolo E. Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot study. Eur J Public Health. 2001; 11: 243-50. [ Links ]

    23. Viitanen P, Vartiainen H, Aarnio J, von Gruenewaldt V, Hakamäki S, Lintonen T, et al. Hepatitis A, B, C and HIV infections among Finnish female prisoners - Young females a risk group. J Infect. 2011; 62: 59-66. [ Links ]

    24. Marques NM, Margalho R, Melo MJ, Cunha JG, Meliço-Silvestre AA. Seroepidemiological survey of transmissible infectious diseases in a Portuguese prison establishment. Braz J Infect Dis. 2011; 15: 272-5. [ Links ]

    25. Malliori M, Sypsa V, Psichogiou M, Touloumi G, Skoutelis A. A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction. 1998; 93: 243-51. [ Links ]

    26. Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, et al. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol. 2005; 76: 311-7. [ Links ]

    27. Danis K, Doherty L, McCartney M, McCarroll J, Kennedy H. Hepatitis and HIV in Northern Ireland prisons: a cross-sectional study. Euro Surveill. 2007; 12 (1):pii=674. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=674 [ Links ]

    28. Christensen PB, Krarup HB, Niesters HG, Norder H, Georgsen J. Prevalence and incidence of bloodborne viral infections among Danish prisoners. Eur J Epidemiol. 2000; 16: 1043-9. [ Links ]

    29. Bird AG, Gore SM, Jolliffe DW, Burns SM. Anonymous HIV surveillance in Saughton Prison, Edinburgh. AIDS. 1992; 6: 725-33. [ Links ]

    30. Gore SM, Bird AG, Burns SM, Goldberg DJ, Ross AJ, Macgregor J. Drug injection and HIV prevalence in inmates of Glenochil prison. BMJ. 1995; 310: 293-6. [ Links ]

    31. Staneková D, Ondrejka D, Habeková M, Wimmerrová S, Kucerková S. Pilot study of risk behaviour, voluntary HIV counselling and HIV antibody testing from saliva among inmates of prisons in Slovakia. Cent Eur J Public Health. 2001; 9: 87-90 [ Links ]

    32. Burek V, Horvat J, Butorac K, Mikulic R. Viral hepatitis B, C and HIV infection in Croatian prisons. Epidemiol Infect. 2010; 138: 1610-20. [ Links ]

    33. Nelwan EJ, Van Crevel R, Alisjahbana B, Indrati AK, Dwiyana RF, Nuralam N, et al. Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening. Trop Med Int Health. 2010; 15: 1491-8. [ Links ]

    34. Mahfoud Z, Kassak K, Kreidieh K, Shamra S, Ramia S. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon. J Infect Dev Ctries. 2010; 4: 144-9. [ Links ]

    35. Kazi AM, Shah SA, Jenkins CA, Shepherd BE, Vermund SH. Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan. Int J Infect Dis. 2010;14 Suppl 3: e60-6. [ Links ]

    36. El Ghrari K, Terrab Z, Benchikhi H, Lakhdar H, Jroundi I, Bennani M. Prevalence of syphilis and HIV infection in female prison population in Morocco. East Mediterr Health J. 2007; 13: 774-9. [ Links ]

    37. Nasir A, Todd CS, Stanekzai MR, Bautista CT, Botros BA, Scott PT, et al. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities. Int J Drug Policy. 2011; 22: 145-52. [ Links ]

    38. Gough E, Edwards P. HIV seroprevalence and associated risk factors among male inmates at the Belize Central Prison. Rev Panam Salud Pública. 2009; 25: 292-9. [ Links ]

    39. Sundar M. Ravikumarr KK, Sudarshan MK. A cross-sectional seroprevalence survey for HIV-1 and high risk sexual behaviour of seropositives in a prison in India. Indian J Public Health. 1995; 39: 116-8. [ Links ]

    40. Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction. 2006; 101: 252-66. [ Links ]

    41. Sabbatani S, Giuliani R, Fulgaro C, Paolillo P, Baldi E, Chiodo F. HIVAb, HCVAb and HBsAg seroprevalence among inmates of the prison of Bologna and the effect of counselling on the compliance of proposed tests. Epidemiol Prev. 2004; 28: 163-8. [ Links ]

    42. Rotily M, Galinier-Pujol A, Obadia Y, Moatti JP, Toubiana P, Vernay-Vaisse C, et al. HIV testing, HIV infection and associated risk factors among inmates in south-eastern French prisons. AIDS. 1994; 8: 1341-4. [ Links ]

    43. Thaisri H, Lerwitworapong J, Vongsheree S, Sawanpanyalert P, Chadbanchachai C, Rojanawiwat A, et al. HIV infection and risk factors among Bangkok prisoners, Thailand: a prospective cohort study. BMC Infect Dis. 2003; 3: 25. [ Links ]

    44. Strazza LO, Massad EE, Azevedo RS, Carvalho HB. Behavior associated with HIV and HCV infection in female prison inmates in São Paulo, Brazil. Cad Saude Publica. 2007; 23: 197-205. [ Links ]

    45. Lopes F, Latorre MR, Campos Pignatari AC, Buchalla CM. HIV, HPV, and syphilis prevalence in a women's penitentiary in the city of São Paulo, 1997-1998. Cad Saude Publica. 2001; 17: 1473-80. [ Links ]

    46. Adoga MP, Banwat EB, Forbi JC, Nimzing L, Pam CR, Gyar SD, et al. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. J Infect Dev Ctries. 2009; 3: 539-47. [ Links ]

    47. Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Quaye IK, Hesse IF, et al. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra, Ghana. J Med Microbiol. 2006; 55: 593-7. [ Links ]

    48. Chimphambano C, Komolafe OO, Muula AS. HIV prevalence among prison inmates in a central prison in southern Malawi, 2005. Trop Doct. 2007; 37: 226-8. [ Links ]

    49. Simooya OO, Sanjobo NE, Kaetano L, Sijumbila G, Munkonze FH, Tailoka F, et al. 'Behind walls': a study of HIV risk behaviours and seroprevalence in prisons in Zambia. AIDS. 2001; 15: 1741-4. [ Links ]

    50. Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Boamah I, Adu-Gyamfi C, et al. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study. BMC Infect Dis. 2008; 8: 33. [ Links ]

    51. Bird AG, Gore SM, Cameron S, Ross AJ, Goldberg DJ. Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie. AIDS. 1995; 9: 801-8. [ Links ]

    52. Kallas EG, Varella D, Ceneviva AC, Castelo A. HIV Seroprevalence and Risk Factors in a Brazilian Prison. Braz J Infect Dis. 1998; 2: 197-204. [ Links ]

    53. Koulierakis G, Gnardellis C, Agrafiotis D, Power KG. HIV risk behaviour correlates among injecting drug users in Greek prisons. Addiction. 2000; 95: 1207-16. [ Links ]

    54. Miller ER, Bi P, Ryan P. Hepatitis C virus infection in South Australian prisonenrs: seroprevalence, seroconverrsion and risk factors. Int J Infect Dis. 2009; 13: 2001-8. [ Links ]

    55. Centres for Disease Control and Prevenntion (CDC). HIV transmission among male inmates in a state prison system--Georgia, 1992-2005. MMWR Morb Mortal Wkly Rep. 2006; 55: 421-6. [ Links ]

    56. Jafa K, McElroy P, Fitzpatrick L, Borkowf CB, Macgowan R, Margolis A, et al. HIV transmission in a state prison system, 1988-2005. PLoS One. 2009; 4: e5416. [ Links ]

    57. Jahani MR, Kheirandish P, Hosseini M, Shirzad H, Seyedalinaghi SA, Karami N, et al. HIV seroconversion among injection drug users in detention, Tehran, Iran. AIDS. 2009; 23: 538-40. [ Links ]

    58. Testa AC, Weilandt C, Ncube F, Gill ON. HIV transmission in part of the US prison system: implications for Europe. Euro Surveill. 2006; 11: E060525.2. [ Links ]

    59. Krebs CP, Simmons M. Intraprison HIV transmission: an assessment of whether it occurs, how it occurs, and who is at risk. AIDS Educ Prev. 2002; 14(5 Suppl B): 53-64. [ Links ]

    60. Murcia J, Portilla J, Bedia M, Palazón JM, Sánchez-Payá J, Saiz de la Hoya P, et al. Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison. Enferm Infecc Microbiol Clin. 2009; 27: 206-12. [ Links ]

    61. Barrios LF. Origen y modelos de Programa de Intercambio de Jeringuillas (PIJ) en prisión. Rev Esp Sanid Penit. 2003; 5: 21-9. [ Links ]

    62. Orsi MM, Brochu S. The place of syringe exchange programs in reducing harm in Canadian prisoners. Can J Public Health. 2009; 100: 29-31. [ Links ]

    63. Stark K, Herrm ann U, Ehrhardt S, Bienzle U. A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany. Epidemiol Infect. 2006; 134: 814-9. [ Links ]

    64. Martín V, Caylà JA, Bolea A, Castilla J. Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison. Int J Tuberc Lung Dis. 2000; 4: 41-6. [ Links ]

    65. Hamers F, Phillips A. Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Medicine. 2008; 9 (Supl.2): 6-12. [ Links ]

    66. European Centre for Disease Prevention and Control. HIV Testing: increase uptake and effectiveness in the European Union. Stockholm: ECDC; 2010. [ Links ]